-
June 17, 2013
Simcere Pharmaceutical Group recently announced that it has entered into a strategic agreement with Bristol-Myers ...
-
June 17, 2013
Bristol-Myers and partner AbbVie presented data on elotuzumab from a phase II study.
-
June 13, 2013
Bristol-Myers presented encouraging long-term data from a phase IIIb study on Orencia.
-
June 12, 2013
Novartis is a well-balanced, high-quality pharma with growth credentials, but also a fair valuation today.
-
June 10, 2013
As investors were picking up the pieces after the dot-com implosion, they came across another troubled sector. A ...
-
June 10, 2013
The NDA on Gilead's sofosbuvir will be reviewed on a priority basis by the FDA.
-
June 08, 2013
It is not unusual for stocks on a tear to overrun their mean price targets, which is a signal of how far analysts on ...
-
May 21, 2013
Roche has one of the best long-term growth profiles in the Big Pharma space
-
May 21, 2013
A big rally has brought Pfizer back to fair value.
-
May 09, 2013
Teva's partnership with Alexza looks like an expensive gamble.
-
April 17, 2013
The pharmaceutical industry is under pressure to do more with less. That means it will be farming out many of is ...
-
February 11, 2013
The Medicines Company (MDCO) recently announced that its two-year global collaboration agreement for Recothrom with ...
-
February 08, 2013
Vical Inc. (VICL) suffered a net loss per share of 9 cents in the fourth quarter of 2012, narrower than the Zacks ...
-
February 08, 2013
Sanofi (SNY) reported fourth quarter 2012 business earnings of 77 cents per American Depository Share (ADS), in line ...
-
February 07, 2013
Idenix Pharmaceuticals, Inc. (IDIX) recently announced that the company has decided to discontinue its clinical ...
-
February 05, 2013
Brightcove Inc. (BCOV) reported a loss of 13 cents in the fourth quarter of 2012, wider than the Zacks Consensus ...
-
February 01, 2013
Alkermes plc (ALKS) reported earnings of 14 cents per share in the third quarter of fiscal 2013 (ended December 31, ...
-
January 30, 2013
Better-than-expected quarterly results once again guided the S&P 500 and the Dow Jones into the green on Tuesday. ...
-
January 29, 2013
We are in the midst of the fourth quarter earnings season and it is once again time to review the players in the ...
-
January 29, 2013
We are in the midst of the fourth quarter earnings season and it is once again time to review the players in the ...
